{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Hugh%20Gaffney&_page=0&_properties=tablingMember.label,answer.attachment.fileName,tablingMemberPrinted&_sort=-answer.answeringMember.label&max-answer.questionFirstAnswered.=2018-03-26T16:33:17.323Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Hugh%20Gaffney&_properties=tablingMember.label,answer.attachment.fileName,tablingMemberPrinted&_sort=-answer.answeringMember.label&max-answer.questionFirstAnswered.=2018-03-26T16:33:17.323Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Hugh%20Gaffney&_page=0&_properties=tablingMember.label,answer.attachment.fileName,tablingMemberPrinted&_metadata=all&_sort=-answer.answeringMember.label&max-answer.questionFirstAnswered.=2018-03-26T16:33:17.323Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Hugh%20Gaffney&_page=0&_properties=tablingMember.label,answer.attachment.fileName,tablingMemberPrinted&_sort=-answer.answeringMember.label&max-answer.questionFirstAnswered.=2018-03-26T16:33:17.323Z", "isPartOf" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Hugh%20Gaffney&_properties=tablingMember.label,answer.attachment.fileName,tablingMemberPrinted&_sort=-answer.answeringMember.label&max-answer.questionFirstAnswered.=2018-03-26T16:33:17.323Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Hugh%20Gaffney&_properties=tablingMember.label,answer.attachment.fileName,tablingMemberPrinted&_sort=-answer.answeringMember.label&max-answer.questionFirstAnswered.=2018-03-26T16:33:17.323Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Hugh%20Gaffney&_page=0&_properties=tablingMember.label,answer.attachment.fileName,tablingMemberPrinted&_sort=-answer.answeringMember.label&max-answer.questionFirstAnswered.=2018-03-26T16:33:17.323Z", "type" : "http://purl.org/linked-data/api/vocab#ListEndpoint"} , "items" : [{"_about" : "http://data.parliament.uk/resources/862326", "AnsweringBody" : [{"_value" : "Department for Exiting the European Union "} ], "answer" : {"_about" : "http://data.parliament.uk/resources/862326/answer", "answerText" : {"_value" : "
The Secretary of State\u2019s future travel programme takes into account a range of high priority issues. The Secretary of State has been to the border, prior to his appointment to his current role, and is very much apprised of the sensitivities and importance of this critical issue.<\/p>
<\/p>
He previously visited Northern Ireland in September 2016 meeting with the then Northern Ireland Executive and stakeholders. Parliamentary Under Secretary of State, Robin Walker MP, visited Northern Ireland with former Northern Ireland Office Minister Chloe Smith in September 2017, visiting the border and meeting with Re-Gen waste and InterTradeIreland.<\/p>
<\/p>
Northern Ireland Office Ministers have also conducted an extensive programme of engagement in Northern Ireland on EU exit with a wide range of stakeholders. The Secretary of State for Northern Ireland visited the border earlier this month.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4475", "label" : {"_value" : "Biography information for Suella Braverman"} } , "answeringMemberConstituency" : {"_value" : "Fareham"} , "answeringMemberPrinted" : {"_value" : "Suella Fernandes"} , "dateOfAnswer" : {"_value" : "2018-03-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-03-20T16:06:26.52Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "203"} , "answeringDeptShortName" : {"_value" : "Exiting the European Union "} , "answeringDeptSortName" : {"_value" : "Exiting the European Union "} , "date" : {"_value" : "2018-03-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Borders: Northern Ireland"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Exiting the European Union, what plans the Secretary of State has to visit the border between the Republic of Ireland and Northern Ireland in the next 12 months.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4614", "label" : {"_value" : "Biography information for Hugh Gaffney"} } , "tablingMemberConstituency" : {"_value" : "Coatbridge, Chryston and Bellshill"} , "tablingMemberPrinted" : [{"_value" : "Hugh Gaffney"} ], "uin" : "132745"} , {"_about" : "http://data.parliament.uk/resources/867081", "AnsweringBody" : [{"_value" : "Department for Exiting the European Union "} ], "answer" : {"_about" : "http://data.parliament.uk/resources/867081/answer", "answerText" : {"_value" : "
Throughout this process, Ministers and senior officials from the Department for Exiting the European Union have spoken with delegates from groups representing UK nationals in the EU, including representatives of British in Europe, to hear their views and concerns. Our Embassies and Ambassadors in the EU 27 have also engaged extensively with the UK communities in their host states.<\/p>
During the last five years, NHS England commissioned a health technology assessment to review the clinical evidence for Kalydeco (Ivacaftor) and decided at the time that it would support its use to treat one gene mutation. Subsequently it has broadened use for other gene mutations following further evidence reviews.<\/p> <\/p> For commissioned drugs such as Kalydeco (Ivacaftor) for named mutations, prescribing decisions are made by multidisciplinary teams in hospitals commissioned by NHS England to provide specialised services for adults and children with cystic fibrosis.<\/p> <\/p> NHS England is investing significant resources into the provision of Kalydeco which works directly on the genes causing cystic fibrosis and in medicines that reduce the impact of the disease.<\/p> <\/p> NHS England and the Cystic Fibrosis Trust jointly collect outcomes data through the Cystic Fibrosis Registry to inform better management of the disease.<\/p> <\/p> Information about specialised National Health Service commissioning is available at the following link:<\/p>
<\/strong>All UK nationals legally resident in the EU before the end of the implementation period, 31 December 2020, will fall under the Citizens\u2019 Rights part of Withdrawal Agreement. This is an agreement that gives people more certainty about residence, healthcare, pensions and other benefits. As negotiations progress we will continue to work in the interests of our nationals to reach a final deal that is in the mutual interests of citizens living across the continent.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4475", "label" : {"_value" : "Biography information for Suella Braverman"}
}
, "answeringMemberConstituency" : {"_value" : "Fareham"}
, "answeringMemberPrinted" : {"_value" : "Suella Fernandes"}
, "dateOfAnswer" : {"_value" : "2018-03-26", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-26T16:33:17.323Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "203"}
, "answeringDeptShortName" : {"_value" : "Exiting the European Union "}
, "answeringDeptSortName" : {"_value" : "Exiting the European Union "}
, "date" : {"_value" : "2018-03-19", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "British Nationals Abroad: EU Countries"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Exiting the European Union, what plans he has to meet representatives of British in Europe to discuss the effect of the UK leaving the EU on UK citizens living in non-UK, EU countries.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4614", "label" : {"_value" : "Biography information for Hugh Gaffney"}
}
, "tablingMemberConstituency" : {"_value" : "Coatbridge, Chryston and Bellshill"}
, "tablingMemberPrinted" : [{"_value" : "Hugh Gaffney"}
], "uin" : "133199"}
, {"_about" : "http://data.parliament.uk/resources/837498", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/837498/answer", "answerText" : {"_value" : "